...

Merus N.V.

Visit website

About the employer

Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics®, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical studies to have similar features as conventional monoclonal antibodies, such as long half-life and low immunogenicity.

Discover related jobs

Discover similar employers

...
University of Twente Hengelo, Netherlands 37 open positions
...
Leiden University Leiden, Netherlands 15 open positions
...
Radboud University Nijmegen, Netherlands 11 open positions
...
AMOLF Amsterdam, Netherlands 6 open positions
...
NIOZ Royal Netherlands Institute for Sea Research Den Helder, Netherlands 2 open positions
More employers